Contact-system activation in children with vasculitis

Lancet

Volumn 360, Issue 9332, 2002, Pages 535-541

  Kahn, Robin ^a   Herwald, Heiko ^a   Müller Esterl, Werner ^b   Schmitt, Roland ^a   Sjögren, Ann Christine ^a   Truedsson, Lennart ^a   Karpman, Diana ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; HEPARIN BINDING PROTEIN; HIGH MOLECULAR WEIGHT KININOGEN;

ADOLESCENT; ADULT; ANAPHYLACTOID PURPURA; ARTHRITIS; ARTICLE; BLOOD ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY BIOPSY; LEUKOCYTOCLASTIC VASCULITIS; MALE; NEPHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; SKIN BIOPSY; SKIN INFLAMMATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0037125571     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09743-X     Document Type: Article

References (36)

1. Colman R.W., Schmaier A.H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood. 90:1997;3819-3843.
2. Gustafson E.J., Schmaier A.H., Wachtfogel Y.T., Kaufman N., Kucich U., Colman R.W. Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest. 84:1989;28-35.
3. Mahabeer R., Bhoola K.D. Kallikrein and kinin receptor genes. Pharmacol Ther. 88:2000;77-89.
4. Regoli D., Nsa Allogho S., Rizzi A., Gobeil F.J. Bradykinin receptors and their antagonists. Eur J Pharmacol. 348:1998;1-10.
5. van der Graaf F., Keus F.J., Vlooswijk R.A., Bouma B.N. The contact activation mechanism in human plasma: activation induced by dextran sulfate. Blood. 59:1982;1225-1233.
6. Schapira M., Silver L.D., Scott C.F., et al. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med. 308:1983;1050-1053.
7. Pixley R.A., Colman R.W. The kallikrein-kinin system in sepsis syndrome. Farmer S.G., Handbook of immunopharmacology: the kinin system. 1997;173-186 Academic Press, New York.
8. Mattsson E., Herwald H., Cramer H., Persson K., Sjobring U., Bjorck L. Staphylococcus aureus induces release of bradykinin in human plasma. Infect Immun. 69:2001;3877-3882.
9. Stadnicki A., Gonciarz M., Niewiarowski T.J., et al. Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis. Dig Dis Sci. 42:1997;2356-2366.
10. Bergamaschini L., Parnetti L., Pareyson D., Canziani S., Cugno M., Agostoni A. Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 12:1998;102-108.
11. Wachtfogel Y.T., Harpel P.C., Edmunds L.H. Jr, Colman R.W. Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass. Blood. 73:1989;468-471.
12. Kaplan A.P., Kay A.B., Austen K.F. A prealbumin activator of prekallikrein, 3: appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 135:1972;81-97.
13. Wachtfogel Y.T., Kucich U., James H.L., et al. Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest. 72:1983;1672-1677.
14. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 44:1992;1-80.
15. Jennette J.C., Falk R.J. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis. 15:1990;517-529.
16. Savige J., Davies D., Falk R.J., Jennette J.C., Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 57:2000;846-862.
17. Bank U., Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol. 69:2001;197-206.
18. Pereira H.A. CAP37, a neutrophil-derived multifunctional inflammatory mediator. J Leukoc Biol. 57:1995;805-812.
19. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 37:1994;187-192.
20. Kaufmann J., Haasemann M., Modrow S., Müller-Esterl W. Structural dissection of the multidomain kininogens: fine mapping of the target epitopes of antibodies interfering with their functional properties. J Biol Chem. 268:1993;9079-9091.
21. Hasan A.H.K., Cines D.B., Herwald H., Schmaier A.H., Müller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J Biol Chem. 270:1995;19256-19261.
22. Müller-Esterl W., Johnson D., Salvesen G., Barrett A.A. Human kininogens. Methods Enzymol. 163:1988;240-256.
23. Herwald H., Collin M., Müller-Esterl W., Björck L. Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism. J Exp Med. 184:1996;665-673.
24. Yang H.Y., Erdos E.G., Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta. 214:1970;374-376.
25. Buttery J.E., Stuart S. Assessment and optimization of kinetic methods for angiotensin-converting enzyme in plasma. Clin Chem. 39:1993;312-316.
26. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
27. Verpy E., Couture-Tosi E., Eldering E., et al. Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J Clin Invest. 95:1995;350-359.
28. Tapper H., Karlsson A., Mörgelin M., Flodgaard H., Herwald H. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood. 99:2002;1785-1793.
29. Bjartell A., Laine S., Pettersson K., Nilsson E., Lovgren T., Lilja H. Time-resolved fluorescence in immunocytochemical detection of prostate-specific antigen in prostatic tissue sections. Histochem J. 31:1999;45-52.
30. Volpe A.R., Fontecchio G., Carmignani M. Regulatory role of bradykinin in the coronary and cerebral circulations and in systemic hemodynamics. Immunopharmacology. 44:1999;87-92.
31. Gautam N., Olofsson A.M., Herwald H., et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med. 7:2001;1123-1127.
32. Zhao M.H., Lockwood C.M. Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis. Clin Exp Immunol. 103:1996;397-402.
33. Reddigari S., Silverberg M., Kaplan A.P. Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells. Int Arch Allergy Immunol. 107:1995;93-94.
34. Pullmannjjj R., Lukac J., Skerenova M., et al. Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene. Clin Exp Rheumatol. 17:1999;593-596.
35. Yoshioka T., Xu Y.X., Yoshida H., Shiraga H., Muraki T., Ito K. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child. 79:1998;394-399.
36. Dudley J., Afifi E., Gardner A., Tizard E.J., McGraw M.E. Polymorphism of the ACE gene in Henoch-Schönlein purpura nephritis. Pediatr Nephrol. 14:2000;218-220.